Description

5-((4-(4-(Diethylamino)Butyl)-1-Piperidinyl)Acetyl)-10,11-Dihydrobenzo(B,E)(1,4)Diazepine-11-One is a high-purity, complex organic compound of significant interest in advanced pharmaceutical research and development. This molecule serves as a critical intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents, particularly those targeting the central nervous system. It is essential for R&D chemists and process development scientists in the pharmaceutical and fine chemical industries seeking to develop new drug candidates with specific receptor-binding profiles.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel psychoactive pharmaceuticals and neuropharmacological agents.
• Research & Development: Used in academic and industrial R&D for studying structure-activity relationships (SAR) and developing new chemical entities (NCEs).
• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a precursor or core structure in the multi-step synthesis of potential APIs for clinical trials.
• Biochemical Research: Employed as a ligand or probe in biochemical assays to investigate specific receptor interactions and signaling pathways.
• Process Chemistry: Utilized in scale-up and optimization studies for the commercial manufacturing of specialized fine chemicals.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in analytical laboratories.

Basic Information

Product Name	5-((4-(4-(Diethylamino)Butyl)-1-Piperidinyl)Acetyl)-10,11-Dihydrobenzo(B,E)(1,4)Diazepine-11-One
CAS No.	142860-99-9
Molecular Formula	C28H38N4O2
Molecular Weight	462.63 g/mol
Synonyms	10,11-Dihydro-5-[2-[4-[4-(diethylamino)butyl]-1-piperidinyl]acetyl]-5H-dibenzo[b,e][1,4]diazepin-11-one; 5-[2-[4-[4-(Diethylamino)butyl]-1-piperidinyl]acetyl]-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-11-one; Dibenzo[b,e][1,4]diazepin-11(10H)-one, 10,11-dihydro-5-[2-[4-[4-(diethylamino)butyl]-1-piperidinyl]acetyl]-; 142860-99-9; DBED derivative; Piperidinylacetyl dibenzodiazepinone derivative.
EINECS	Contact for details

Quality Control

Our 5-((4-(4-(Diethylamino)Butyl)-1-Piperidinyl)Acetyl)-10,11-Dihydrobenzo(B,E)(1,4)Diazepine-11-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure compliance with research-grade and pharmaceutical intermediate standards. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a desiccated environment and away from direct light exposure to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.